Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
experience measured from the date stated on the PhD diploma. The application must be in English The research proposal must be relevant to the Gaia programme mission of climate mitigation, adaptation, and the
-
healthcare data. * A team player who thrives as a member of a highly functional cross-disciplinary team Preferred Elements * B.S, M.S., and/or PhD in Computer Science, Biomedical Informatics, Machine Learning
-
with therapeutic response and resistance to RAS inhibition in non-small cell lung cancer (NSCLC) in the laboratory of Ferdinandos Skoulidis, MD, PhD, at the University of Texas MD Anderson Cancer Center
-
Foundations. 360 000 SEK each year and is taxfree. Qualifications We seek a driven and motivated bioinformatician to contribute to our research program Eligibility: A PhD (or foreign degree deemed equivalent
-
) provides an outstanding multidisciplinary environment that underpins the BHF Centre’s research strengths. SCMMS hosts more than 65 academic groups and around 400 staff and 110 PhD students, spanning
-
these discoveries into new therapeutic strategies. Individual projects will be tailored to the candidate’s background and interests, with additional opportunities for collaborative work with the Cancer Program at
-
1, 2026, with fellowships starting as early as May. Both QCB and the University of Illinois Urbana-Champaign are diverse, inclusive communities. Anyone with a PhD earned in the past 10 years, or have
-
on the production and in vitro characterization of several enzymes in parallel (proteases and hydrolases). This research programme is part of an international effort to answer the call for the development of new
-
The Gaia Postdoctoral Fellowship Programme, funded by the EU under the Marie Sklodowska-Curie Actions (MSCA), offers 6 additional positions across to the already 9 existing fellowship, in this final
-
part of the eDyNAmiC Cancer Grand Challenge. TRACERx is a UK-wide lung cancer evolution programme which started in 2014 and has to date recruited over 820 patients. It is the first longitudinal cancer